Total Payments
$6,968
2024 Payments
$1,504
Companies
40
Transactions
418
Medicare Patients
1,460
Medicare Billing
$148,938
Payment Breakdown by Category
Food & Beverage$6,968 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,968 | 418 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,634 | 117 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $675.32 | 39 | $0 (2024) |
| Lilly USA, LLC | $643.07 | 30 | $0 (2024) |
| PFIZER INC. | $485.06 | 26 | $0 (2024) |
| Amgen Inc. | $416.71 | 25 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $370.86 | 26 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $282.90 | 18 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $241.77 | 15 | $0 (2021) |
| Corium, LLC | $238.26 | 6 | $0 (2023) |
| Novo Nordisk Inc | $232.21 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,504 | 78 | AstraZeneca Pharmaceuticals LP ($283.91) |
| 2023 | $1,722 | 96 | ABBVIE INC. ($470.93) |
| 2022 | $1,799 | 119 | ABBVIE INC. ($379.19) |
| 2021 | $1,942 | 125 | AbbVie Inc. ($517.47) |
All Payment Transactions
418 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Central Nervous System | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: PAIN | ||||||
| 10/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: PAIN | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: PAIN | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Obesity | ||||||
| 08/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Gastroenterology | ||||||
| 07/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 463 | 822 | $196,445 | $49,935 |
| 2022 | 12 | 466 | 664 | $162,731 | $42,370 |
| 2021 | 10 | 348 | 513 | $135,155 | $37,369 |
| 2020 | 7 | 183 | 284 | $80,560 | $19,264 |
Total Patients
1,460
Total Services
2,283
Medicare Billing
$148,938
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 260 | $79,040 | $17,714 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 87 | $35,235 | $9,337 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $26,134 | $7,833 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 92 | $18,952 | $4,177 | 22.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 83 | $12,201 | $2,639 | 21.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 64 | $7,360 | $2,562 | 34.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $6,692 | $1,920 | 28.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $3,912 | $1,726 | 44.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 16 | 19 | $3,496 | $975.41 | 27.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,898 | $783.90 | 41.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 40 | 65 | $520.00 | $143.00 | 27.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $1,005 | $124.41 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 206 | $62,624 | $14,705 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $24,628 | $7,632 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 65 | $26,325 | $7,073 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 122 | $25,132 | $6,766 | 26.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $7,170 | $2,121 | 29.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $3,423 | $1,436 | 42.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 35 | 41 | $7,544 | $1,260 | 16.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $1,679 | $675.42 | 40.2% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 11 | 12 | $2,281 | $255.37 | 11.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 12 | 12 | $456.00 | $195.54 | 42.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 40 | 65 | $520.00 | $142.27 | 27.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 13 | $949.00 | $108.45 | 11.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 167 | $50,768 | $13,292 | 26.2% |
About Mahealani Roach, FNP
Mahealani Roach, FNP is a Family healthcare provider based in Powhatan, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2019. The National Provider Identifier (NPI) number assigned to this provider is 1649730292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mahealani Roach, FNP has received a total of $6,968 in payments from pharmaceutical and medical device companies, with $1,504 received in 2024. These payments were reported across 418 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,968).
As a Medicare-enrolled provider, Roach has provided services to 1,460 Medicare beneficiaries, totaling 2,283 services with total Medicare billing of $148,938. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Powhatan, VA
- Active Since 03/20/2019
- Last Updated 03/25/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1649730292
Products in Payments
- VRAYLAR (Drug) $806.78
- NURTEC ODT (Drug) $706.70
- QULIPTA (Drug) $475.13
- XIFAXAN (Drug) $370.86
- UBRELVY (Drug) $352.34
- FARXIGA (Drug) $292.79
- Otezla (Drug) $236.38
- BREZTRI (Drug) $232.44
- Azstarys (Drug) $219.84
- MOUNJARO (Drug) $203.56
- TRINTELLIX (Drug) $178.30
- Vascepa (Drug) $164.81
- ELIQUIS (Drug) $154.50
- EMGALITY (Drug) $141.65
- Coala Heart Monitor (Device) $140.04
- Aimovig (Biological) $139.37
- TRULICITY (Drug) $119.39
- NEXLETOL (Drug) $118.26
- ZEPBOUND (Drug) $107.10
- TOSYMRA (Drug) $106.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Powhatan
Nicole Cole
Family — Payments: $1,752
Family $1,752
Mrs. Christina Graham, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $1,174
Family $1,174
Charles Pfeiffer, N. P, N. P
Family — Payments: $320.10
Family $320.10
Madeline Staley, Fnp-Bc, FNP-BC
Family — Payments: $93.30
Family $93.30
Kelly Anderson, Np, NP
Family — Payments: $37.60
Family $37.60
Emily Love, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $15.23
Family $15.23